Search research articles
Contact Us
Filters
Showing results (231-240 of 242) with videos related to
Page
of 25
Sort By:
The Journal of Urology
|
January 1, 1992
Immunotherapy with interleukin-2 and alpha-interferon in patients with metastatic renal cell cancer with in situ primary cancers: a pilot study
W F Spencer, W M Linehan, M M Walther, et al.
Scandinavian Journal of Immunology
|
September 1, 1996
Recognition of human renal cell carcinoma and melanoma by HLA-A2-restricted cytotoxic T lymphocytes is mediated by shared peptide epitopes and up-regulated by interferon-gamma
H Bernhard, M J Maeurer, E Jäger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 24, 1999
High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993
M B Atkins, M T Lotze, J P Dutcher, et al.
Cancer Research
|
April 6, 2001
Immunization with an antigen identified by cytokine tumor vaccine-assisted SEREX (CAS) suppressed growth of the rat 9L glioma in vivo
H Okada, J Attanucci, K M Giezeman-Smits, et al.
Oncogene
|
July 13, 2010
HMGB1 release and redox regulates autophagy and apoptosis in cancer cells
D Tang, R Kang, C-W Cheh, et al.
Molecular Psychiatry
|
August 6, 2014
Plasma biosignature and brain pathology related to persistent cognitive impairment in late-life depression
B S Diniz, E Sibille, Y Ding, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 7, 1998
Autologous human monocyte-derived dendritic cells genetically modified to express melanoma antigens elicit primary cytotoxic T cell responses in vitro: enhancement by cotransfection of genes encoding the Th1-biasing cytokines IL-12 and IFN-alpha
T Tüting, C C Wilson, D M Martin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 1, 1997
Phase I evaluation of intravenous recombinant human interleukin 12 in patients with advanced malignancies
M B Atkins, M J Robertson, M Gordon, et al.
Cancer Biomarkers : Section a of Disease Markers
|
December 29, 2006
Multianalyte profiling of serum cytokines for detection of pancreatic cancer
H J Zeh, S Winikoff, D P Landsittel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 1, 2019
Efficacy of adoptive therapy with tumor-infiltrating lymphocytes and recombinant interleukin-2 in advanced cutaneous melanoma: a systematic review and meta-analysis
U Dafni, O Michielin, S Martin Lluesma, et al.
Page
of 25
Search research articles
Search
Showing results (231-240 of 242) with videos related to
Sort By:
Page
of 25
The Journal of Urology
|
January 1, 1992
Immunotherapy with interleukin-2 and alpha-interferon in patients with metastatic renal cell cancer with in situ primary cancers: a pilot study
W F Spencer, W M Linehan, M M Walther, et al.
Scandinavian Journal of Immunology
|
September 1, 1996
Recognition of human renal cell carcinoma and melanoma by HLA-A2-restricted cytotoxic T lymphocytes is mediated by shared peptide epitopes and up-regulated by interferon-gamma
H Bernhard, M J Maeurer, E Jäger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 24, 1999
High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993
M B Atkins, M T Lotze, J P Dutcher, et al.
Cancer Research
|
April 6, 2001
Immunization with an antigen identified by cytokine tumor vaccine-assisted SEREX (CAS) suppressed growth of the rat 9L glioma in vivo
H Okada, J Attanucci, K M Giezeman-Smits, et al.
Oncogene
|
July 13, 2010
HMGB1 release and redox regulates autophagy and apoptosis in cancer cells
D Tang, R Kang, C-W Cheh, et al.
Molecular Psychiatry
|
August 6, 2014
Plasma biosignature and brain pathology related to persistent cognitive impairment in late-life depression
B S Diniz, E Sibille, Y Ding, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 7, 1998
Autologous human monocyte-derived dendritic cells genetically modified to express melanoma antigens elicit primary cytotoxic T cell responses in vitro: enhancement by cotransfection of genes encoding the Th1-biasing cytokines IL-12 and IFN-alpha
T Tüting, C C Wilson, D M Martin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 1, 1997
Phase I evaluation of intravenous recombinant human interleukin 12 in patients with advanced malignancies
M B Atkins, M J Robertson, M Gordon, et al.
Cancer Biomarkers : Section a of Disease Markers
|
December 29, 2006
Multianalyte profiling of serum cytokines for detection of pancreatic cancer
H J Zeh, S Winikoff, D P Landsittel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 1, 2019
Efficacy of adoptive therapy with tumor-infiltrating lymphocytes and recombinant interleukin-2 in advanced cutaneous melanoma: a systematic review and meta-analysis
U Dafni, O Michielin, S Martin Lluesma, et al.
Page
of 25